- $801.08m
- $669.44m
- $0.21m
Chimerix gains on $25 million smallpox drug contract
Chimerix gets up to $25.3 mln contract from Canada for smallpox drug
U.S. STOCKS ON THE MOVE-WeWork, Rite Aid, Snowflake
U.S. STOCKS ON THE MOVE-WeWork, Novavax, Smart for Life, F-star Therapeutics
U.S. STOCKS ON THE MOVE-Rite Aid, Soligenix, F-star Therapeutics
Brief: Chimerix Announces $9.3 Million International Tembexa Procurement Agreement
U.S. STOCKS ON THE MOVE-Snowflake Inc, KB Home, Occidental Petroleum
Smallpox vaccine, drug makers rise as WHO to decide on monkeypox 'emergency'
U.S. STOCKS ON THE MOVE-Microsoft, Ciena, nCino,
U.S. STOCKS ON THE MOVE-Immunic, UiPath, Blue Apron
EU drugs watchdog in talks with Bavarian Nordic over wider use of smallpox vaccine
U.S. STOCKS ON THE MOVE-C3.ai, Chewy, oil companies
Bluebird, Chimerix, Clovis have under 6 months of cash left - Truist
Cowen sees revenue oppurtunity for smallpox vaccine makers in EU
Smallpox drugmakers jump as WHO calls for increased Monkeypox surveillance
Explainer: What vaccines, treatments do we have to combat monkeypox?
U.S. STOCKS ON THE MOVE-JPMorgan, Citigroup, Broadcom, VMware
U.S. STOCKS ON THE MOVE-JPMorgan, Etsy, Ross Stores, VMware
Smallpox drugmakers rally as WHO expects more cases of monkeypox